HOLLISTON, Mass., Feb. 8, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, is pleased to announce that its LB2 Lung Regeneration Bioreactor was featured on PBS's Nova ScienceNow television program on January 27, 2011. The lung research and transplantation work was conducted by Dr. Harald Ott at Massachusetts General Hospital.
PBS's Nova ScienceNow Features Harvard Bioscience Bioreactors For Lung And Airway Regeneration
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts